The effect of nalidixic acid on deoxyribonucleic acid (DNA) synthesis in Bacillus subtilis cells infected with bacteriophage SPOI was studied. Nalidixic acid had little inhibitory effect on SPO1 DNA synthesis at concentrations that drastically inhibited B. subtilis DNA synthesis. Inhibition of DNA synthesis, appropriate to the concentration used, was imposed within 1 min after addition of nalidixic acid, suggesting that it acts directly on DNA synthesis in both infected and uninfected cells. The SPOl DNA synthesized in the presence of high concentrations of nalidixic acid had a density characteristic of normal SPOl DNA and was packaged into viable progeny phage particles, but its rate of synthesis was reduced and bacterial lysis was delayed.
Nalidixic acid (1 ,4-dihydro-l-ethyl-7-methyl-4-oxo-1, 8-naphthyridine-3-carboxylic acid) is a selective inhibitor of deoxyribonucleic acid (DNA) synthesis in growing Escherichia coli (4, 5) and Bacillus subtilis (2) cells. It does not appreciably affect bacterial ribonucleic acid (RNA) or protein synthesis at concentrations that strongly inhibit bacterial DNA synthesis, although the basis for this selectivity and the mechanism of its action are unknown.
In this paper, we demonstrate that nalidixic acid has a weak inhibitory effect upon phage SPOI DNA synthesis, at concentrations that drastically inhibit uninfected B. subtilis DNA synthesis.
MATERIALS AND METHODS
Bacteria. All experiments were performed with B. subtilis HA101, a multiple auxotroph requiring histidine, methionine, and leucine, and nonpermissive for a class of phage SPOI mutants (7) . HA101 was generously provided by S. Okubo. Phage. SPOl wild type (6) and SPOI Sus F30 were used. Sus F30, a suppressible mutant of SPOI isolated by one of us (D.J.F.), grows on the permissive host HA101-B, an su+ derivative of HAIOI (7) . Sus F30 does not synthesize phage DNA (DO) in nonpermissive hosts (HAIOI or 168 M).
Media. HML medium contained (per liter): glucose, I Predoctoral trainee, U.S. Public Health Service Virology Training Grant Al 00238. 2 Predoctoral trainee, Public Health Service Training Grant GM 00603. 96 5 g; L-histidine, 50 mg; L-methionine, 50 mg; L-leucine, 50 mg; NBS, 5 ml; and minimal salts medium (1), 995 ml. L medium is HML medium without histidine and methionine. NBS is NY medium without yeast extract (6) .
Phage preparation. Wild-type phage were prepared in CHT-50 medium (1), supplemented with 5 X 10-4 M CaCl2 and 0.1% casein hydrolysate, essentially according to standard procedures (6) . Sus F30 stocks were prepared on the HA101-B host in L medium.
Nalidixic acid. Nalidixic acid was a generous gift of S. Archer, Sterling-Winthrop Research Institute. Stock solutions were made by dissolving the agent in dimethylsulfoxide (DMSO) at a concentration of 6.0 mg/ml, and were stored frozen. Prior to use, further dilutions were made into growth medium at 37 C. Concentrations were standardized spectrophotometrically (E257 n. = 1.1 X 105 cm2/g). All cultures of any single experiment contained uniform amounts of DMSO (<0.8%) during the period of exposure to nalidixic acid. There was no observable effect of DMSO on uninfected or infected cells at the concentration used.
Phage infection. All experiments were carried out at 37 C. Bacteria were grown to 108 to 1.8 X 108 cells/ml and were infected at multiplicities of 6 to 10 with SPOI. At 37 C, in HML medium, the bacterial doubling time was 40 min, the SPOI eclipse period was 28 min, cell lysis began at 35 min, and the average burst was about 80 phage per infectious center.
Incorporation of labeled adenine into DNA. Incorporation of adenine-8-14C into alkali-stable, trichloroacetic acid-precipitable material was used as a measure of DNA synthesis. For most experiments, 1-ml sam-acid containing 1 mg of unlabeled adenine per ml, chilled, and diluted further with 2 ml of 5% trichloroacetic acid. Fractions from CsCl gradients were added to 1 ml of 0.5 M KOH, with similar subsequent treatment. Precipitates were collected on nitrocellulose membrane filters, washed with 5% trichloroacetic acid containing 100 ,ug of unlabeled adenine per ml, dried, and counted in a scintillation spectrometer in Liquifluor-toluene.
CsCl density gradient centrifugation. At appropriate times, S ml of labeled culture was poured onto S ml of frozen minimal salts medium (1) . Sodium azide was added to 0.01 M, and the cells were separated by low-speed centrifugation. The cells were then suspended in 2 ml of SSC (0.15 M NaCl, 0.015 M sodium citrate) supplemented with 0.01 M tris(hydroxymethyl)aminomethane hydrochloride (pH 7.5) and 0.01 M KCI. Lysozyme was added to 300 ;g/ml, and the preparations were quick frozen, thawed, and incubated at 37 C; sarkosyl was added to 1.5%, which caused clearing of the cell suspension. Appropriate quantities of saturated CsCl solution were added, and tubes were centrifuged in an SW39 rotor for 72 hr at 61,000 X g and 22 C. Refractive indices were determined on a representative number of fractions, and then all samples were treated with KOH and trichloroacetic acid as previously described.
One-step growth experiment. HA101 cells (1.8 X 108/ml) were infected with wild-type SPOI at a multiplicity of 6 and aerated at 37 C, at appropriate dilutions. Parallel experiments were carried out in the presence and absence of nalidixic acid (50 ,&g/ml). Intracellular phage were assayed by the method of Geiduschek and Sklar (Nature, in press). Extracellular phage and infectious centers were sampled directly at various times from the appropriately diluted growth tubes, and were plated with indicator bacteria.
RESULTS
The effect of nalidixic acid on DNA synthesis in uninfected and infected cells was measured by incorporation of adenine-8-'4C into alkali-stable, trichloroacetic acid-precipitable material. Alterations in rate or extent of incorporation were assumed to reflect similar alterations in DNA synthesis.
In the first set of experiments, cells were preincubated in nalidixic acid for 5 min before the addition of label, or label and phage. In uninfected cells, bacterial DNA synthesis was strongly inhibited by nalidixic acid (Fig. la) , as has been shown previously (2) , but DNA synthesis in SPOl -infected cells was inhibited to a lesser extent (Fig. lb) . For example, 5 ,ug of nalidixic acid per ml inhibited the total incorporation of label into DNA of uninfected cells at 60 min by 75%, but had no appreciable effect on incorporation into infected cells. A concentration of 25 ,tg/ml inhibited total DNA synthesis in uninfected cells by about 95 % at 60 min, but inhibited total DNA synthesis in infected cells only by about 30%. To determine the rapidity with which inhibition by nalidixic acid is established, the agent was added to infected and uninfected cells actively incorporating label into DNA. In both cases, the inhibitory effect was expressed within 1 min after addition of the drug (Fig. 3) , and the inhibition of bacterial DNA synthesis was again much greater than the inhibition of phage DNA synthesis. Significant inhibition in uninfected cells was evident even with concentrations of the inhibitor as low as 1 ,ug/ml.
Relative incorporation rates, measured at various inhibitor concentrations and plotted as a function of concentration, serve to illustrate the differing extent of inhibition of phage and bacterial DNA synthesis by nalidixic acid (Fig. 4) . Incorporation rates in uninfected cells were determined soon after addition of nalidixic acid to minimize effects of continued cell division. Inhibition in infected cells was determined by comparison of the linear portions of each incorporation curve, thus eliminating consideration of the delay in the onset of synthesis.
In addition to showing the considerable difference in inhibitory effect of nalidixic acid on B. subtilis and SPO1 DNA synthesis, theseresultslead to two other important conclusions: (i) the inhibitory effect of nalidixic acid upon active DNA synthesis is expressed fully within 1 min after addition of the drug (Fig. 3) , and (ii) the extent of inhibition of the ultimate rate of adenine incorporation into phage DNA is the same regardless of whether the inhibitor is added before infection or after phage DNA synthesis has begun (Fig. 4,  curve B) .
The effect of preincubation in nalidixic acid on subsequent phage DNA synthesis was examined by the addition of phage and labeled adenine to cells after various periods of exposure to the UNINFECTED Label NA. inhibitor (Fig. 5) . Preincubation for 5 min resulted in a delay of about 9 min in the onset of phage DNA synthesis as compared with a control infection in the absence of nalidixic acid. Longer exposure to nalidixic acid before infection caused no further effect on the time of onset or on the subsequent rate of phage DNA synthesis, except for a small additional delay of about 5 min in the onset of synthesis in cells exposed for more than 60 min (Fig. 5b) .
Implicit in these results is evidence for two effects of nalidixic acid on DNA synthesis in infected cells. Most obvious is the direct decrease in rate of phage DNA synthesis, which was independent of time of addition of the inhibitor (Fig. 4, curve B) . The other effect, which occurred only if nalidixic acid was present for a period before active phage DNA synthesis, resulted in a delay in the onset of that synthesis (Fig. Sb) .
Similar experiments performed at a low multiplicity of infection (0.7) showed that the differential inhibition of rate of DNA synthesis was independent of the input ratio of phage to bacteria (compare Fig. 6 , curves C and D, with Fig. 3b) . However, the delay in onset of phage DNA synthesis resulting from nalidixic acid addition before infection was longer than at higher multiplicities (compare Fig. 6 , curve E, with Fig. lb) .
In other experiments (data not shown), nalidixic acid added at the time of normal onset of phage DNA synthesis caused a depression in the rate of DNA synthesis, but did not result in a delay in its onset. In addition, visible lysis was delayed to an extent dependent upon inhibitor concentration in infections made in the presence of nalidixic acid, but no such delays were observed when inhibitor additions were made after phage DNA synthesis had begun. Indications of this are evident in Fig. 3b and Fig. 5 synthesis, but did not delay lysis, resulting in lowered incorporation plateaus (Fig. 3b) . However, preincubation of cells in 43 Mg of nalidixic acid per ml delayed lysis so long that higher incorporation plateaus were eventually reached in spite of the delay in onset of replication and the depressed rate of DNA synthesis (Fig. 5) . Although the depression in rate of SPO1 DNA synthesis was dependent only upon the concentration of nalidixic acid, both the delay in onset of DNA synthesis and the delay in lysis were dependent also on the time of addition of the inhibitor. The effect of nalidixic acid on development of viable SPO1 was examined in a "one-step growth" experiment (3). Infection in the presence of 50 MAg of nalidixic acid per ml caused a delay of 30 min in intracellular phage appearance, and a delay of 50 min in lysis (Fig. 7) . These delays appear to be too long to be ascribed only to the inhibitor's effects on DNA synthesis. The production of viable phage progeny, as illustrated in this experiment, is, needless to say, a most critical test of the biological integrity of the DNA synthesized in the presence of the inhibitor. SPOI DNA contains hydroxymethyluracil in place of thymine. Consequently, the DNA of B. subtilis and that of SPOI, although similar in guanine plus cytosine content, have very different densities in CsCl, which allows simple identification of newly synthesized DNA (6) . Uninfected cells were labeled, either in the presence or absence of 50 ,Ag of nalidixic acid per ml, for 40 min before addition of phage, and for an additional period after infection. The DNA was then prepared, and was centrifuged to equilibrium in CsCl (Fig. 8a and b) . Because of the delay in onset and the depressed rate of SPO1 DNA synthesis in the presence of nalidixic acid, the DNA labeling period following infection was adjusted so that the extent of labeled phage DNA synthesis was similar to the control. Because of these considerations, the relative amounts of label accumulated into the SPOt DNA density band are not quantitative measures of phage DNA synthesis in the presence and absence of the inhibitor. However, such a quantitative comparison of bacterial DNA synthesis is possible, since the period of synthesis of labeled bacterial DNA is the same in each case, extending from label addition to phage-induced host shut off. Accumulation of labeled bacterial DNA was about 20 times as great in the absence of nalidixic acid as in its presence, which is entirely consistent with the inhibition of bacterial DNA synthesis by 50 ,ug of nalidixic acid per ml, illustrated in Fig. la and 3a .
Density gradient analysis of DNA prepared after pulse labeling late in infectionin the presence of 50 ,ug of nalidixic acid per ml is shown in Fig.  8c The cause of the concentration-dependent delay in the onset of phage DNA synthesis, the other inhibitory effect, is also not fully understood. One possible explanation is that this delay arises from a secondary effect of the drug, such as a partial inhibition of protein synthesis, which has been observed in uninfected B. subtilis cells after long exposures to high nalidixic acid concentrations (2) . Another possibility is that a partial inhibition of functional SPOI messenger RNA transcription might occur if the drug interacts with phage DNA molecules. Such an effect occurring early in infection might delay the accumulation of SPOI gene products necessary for DNA synthesis, resulting in a delay in the onset of phage DNA synthesis. It is of interest that the lag appears to be multiplicity-dependent and is not observed if the drug is added to infected cells after SPOI DNA synthesis has begun.
Nalidixic acid also caused a delay in the production of intracellular phage, and in cell lysis. The lengths of these delays, at various drug concentrations, were not equivalent to the corresponding delay in the onset of phage DNA synthesis, and were probably influenced by other factors as well. For example, the timing of normal SPOl development and assembly requires a highly ordered pattern of synthesis of DNA, enzymes, and structural proteins, which is dependent upon the integrity of the complexly sequenced SPOl messenger RNA transcription program. A general slowdown in some or all of these steps would result in a substantial delay in intracellular phage development. The observation that no significant delay in lysis occurred if nalidixic acid was added after phage DNA synthesis was well under way may indicate that factors necessary for lysis were rapidly accumulating by that time.
It is of interest to compare our results on SPO1 with previously reported effects of nalidixic acid and mitomycin C on coliphage development. Unlike SPOl, the DNA coliphages T2r, T5, OX174, and R have been reported not to produce infectious progeny particles in the presence of nalidixic acid, although some x induction did occur; DNA synthesis was not measured (11) . A differential inhibition of DNA synthesis in uninfected and T2r-infected E. coli cells was observed in the presence of mitomycin C, but the phage particles produced under these conditions were noninfectious (8) (9) (10) .
In contrast to these results with coliphages, nearly normal SPOl development occurred in the presence of nalidixic acid, and viable progeny particles were produced. These properties suggest that nalidixic acid might be an extremely useful drug in facilitating studies of virus-specific DNA synthesis (certainly for SPO1, and for otherphages as well). For example, it should be especially useful in studies of replication in singly infected cells.
